Last Updated: November 13, 2026

cyproheptadine hydrochloride - Profile

What are the generic drug sources for cyproheptadine hydrochloride and what is the scope of patent protection?

Cyproheptadine hydrochloride is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Chartwell Molecular, Halsey, Morton Grove, Naska, Patrin, Pharm Assoc, Pharmazone, Quagen, Rising, Tris Pharma Inc, Merck, Am Therap, Ascot, Chartwell Rx, Duramed Pharms Barr, Heritage Pharma, Ingenus Pharms Llc, Kenton, Kv Pharm, Md Pharm, Mountain, Mylan, Pioneer Pharms, Pliva, Regcon Holdings, Strides Pharma Intl, Superpharm, Tp Anda Holdings, Vitarine, Watson Labs, and Zydus Pharms, and is included in forty-one NDAs. Additional information is available in the individual branded drug profile pages.

Summary for cyproheptadine hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	32
NDAs:	41

US Patents and Regulatory Information for cyproheptadine hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Mid Atlantic	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	086833-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Chartwell Molecular	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	203191-001	Jul 13, 2017	AA	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Halsey	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	089199-001	Jul 3, 1986		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Morton Grove	CYPROHEPTADINE HYDROCHLORIDE	cyproheptadine hydrochloride	SYRUP;ORAL	087001-001	Nov 4, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.